Clinical Trial Update: Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes testing the combination of ipilimumab and nivolumab with or without cabozantinib in adults with advanced soft tissue s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extraskeletal Myxoid Chondrosarcoma
• Leiomyosarcoma
• Liposarcoma
• Soft Tissue Sarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Cabometyx (cabozantinib)
• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: National Cancer Institute LAO | Conditions: Locally Advanced Extraskeletal Myxoid Chondrosarcoma, Locally Advanced Leiomyosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING